'Preimplantation Genetic Diagnosis 2018: Current Practice and Beyond', 9-10 November 2018
Page URL: https://www.bionews.org.uk/page_92778

Stem cell lines show high genetic variation, study finds

17 January 2011
Appeared in BioNews 591

An international team of researchers has found that both embryonic stem cells (ESCs) and iPS (induced pluripotent stem) cells show higher genetic abnormalities than other cells.

The study, led by stem cell scientists from the University of California, San Diego School of Medicine and The Scripps Research Institute, used a high-resolution molecular technique called SNP (single nucleotide polymorphism) analysis to look for genetic changes at more than a million sites in the human genome.

'We found that human pluripotent cells (hESCs and iPS cells) had higher frequencies of genomic aberrations than other cell types', said lead author Dr Louise Laurent, assistant professor in the UCSD Department of Reproductive Medicine.

'Most strikingly, we observed a higher frequency of genomic duplications in hESCs and deletions in iPS cells, when compared to non-pluripotent samples', she added.

The scientists also identified specific regions in the genome where the abnormalities were more likely to arise. In ESCs, the duplications were near pluripotency-associated genes (genes that allow the cells to turn into any other kind of cell in the body). In iPS cells, duplications involved cell proliferation genes, and deletions involved tumor suppressor genes.

Dr Laurent said: 'We were surprised to see profound genetic changes occurring in some cultures over very short periods of time, such as during the process of reprogramming somatic cells into iPS cells and during differentiation of the cells in culture'.

The ability of pluripotent stem cells to change into other cell types has made them a potential source for cell replacement therapies, but abnormalities like these can push cells towards becoming cancerous and therefore limiting their suitability as therapeutic agents.

'Since genetic aberrations are often associated with cancers, it is vital that cell lines destined for clinical use are free from cancer-associated genomic alterations', explained author Dr Jeanne Loring, Director of the Center for Regenerative Medicine at The Scripps Research Institute.

These changes could not have been detected by traditional microscopic techniques, such as karyotyping, due to the fact that they occur very rapidly. In the past, SNP analysis was not a part of routine monitoring of hESC and iPS cells cultures, but these results suggest that perhaps it should be in order to assure the cells' stability and clinical safety.

'We don't know yet what effects, if any, these genetic abnormalities will have on the outcome of basic research studies or clinical applications, and we need to find out', Dr Laurent said.

She added: 'The results of the study illustrate the need for frequent genomic monitoring of pluripotent stem cell cultures'.

The study was published in the journal Cell Stem Cell.

SOURCES & REFERENCES
Dynamic Changes in the Copy Number of Pluripotency and Cell Proliferation Genes in Human ESCs and iPSCs during Reprogramming and Time in Culture
Cell Stem Cell |  7 January 2011
Genetic abnormalities found in stem cell lines
Los Angeles Times |  6 January 2011
Genetic Abnormalities Identified in Pluripotent Stem Cell Lines - Press Release
UCSD Medical Center |  6 January 2011
Genetic Abnormalities in Embryonic Stem Cells
Family Research Council (FRC) |  7 January 2011
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
23 May 2011 - by Dr Rebecca Robey 
IPS (induced pluripotent stem) cells from mice can be recognised by their own immune system and destroyed, scientists at the University of California, San Diego, have found...
7 February 2011 - by Leo Perfect 
Adult human cells maintain a 'memory' when reprogrammed into a stem cell-like state, US scientists have found. The finding suggests the resulting induced pluripotent stem (iPS) cells are not yet a viable alternative to human embryonic stem (ES) cells for modelling or treating disease...
10 January 2011 - by Dr Rachael Panizzo 
Faulty stem cells may cause the onset of male pattern baldness, scientists have found. Professor George Cotsarelis and colleagues at the University of Pennsylvania School of Medicine in Philadelphia discovered that stem cells are present in the hair follicles of both bald and hairy scalp regions in men with male pattern baldness...
13 September 2010 - by Antony Blackburn-Starza 
A federal appeals court in the US has ruled that federal funding for embryonic stem cell research may continue and an injunction placed on the funding by a lower court last month is temporarily suspended...
4 May 2010 - by Dr Nadeem Shaikh 
US-based scientists working on embryonic stem cell (ES cell) research are relieved that the most important cell lines in their field have been approved for research by new government guidelines. During the Bush administration, US government funding for research involving ES cells was restricted to just 20 cell lines, all of which were in existence before 9 August 2001...
19 April 2010 - by Nishat Hyder 
Over a year since US President Barack Obama announced his decision to allow federal funding for embryonic stem cell research, the widely utilised cell lines, H9 and H7, are still weeks away from receiving federal funding approval. The H9 and H7 cell lines were derived and approved under the Bush administration and are currently owned by WiCell Research Institute in Madison, Wisconsin. However, for months now the fate of these two much used lines has been uncertain. According to...
12 April 2010 - by Dr Rachael Panizzo 
Researchers at the Massachusetts General Hospital Cancer Center and Center for Regenerative Medicine have pinpointed key genetic differences between mouse embryonic stem cells (ES cells) and induced pluripotent stem cells (iPS cells)....
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.